A pair of cases from Academy 2026 show scleral lens refits for severe keratoconus, one addressing focal corneal edema and one fitting around glaucoma tube shunts.
|Videos|April 14, 2022
Nano Magic: product overview, Vision Expo East takeaways
Author(s)Alex Delaney-Gesing, Senior Editor
Nano Magic President/CEO Tom Berman continues his post-Vision Expo East discussion on the company's products as well as his key takeaways from this year's in-person meeting.
Advertisement
Nano Magic President/CEO Tom Berman continues his post-Vision Expo East discussion with Optometry Times®' Alex Delaney-Gesing on the company's products offerings — including lens technology and how eye care professionals can benefit — as well as his key takeaways from this year's in-person meeting.
Watch part I of this interview:
Advertisement
Related to this article
Raman Bhakhri, OD, FAAO, details a session given with Denise Skiadopoulos, OD, FAAO, during the annual AAOpt meeting in Anaheim, California.
Dry eye questionnaires capture only 22.4% of Demodex blepharitis symptoms, and a 22-study review links Demodex infestation to worse meibomian gland function.
Shane Kannarr, OD, overviews results from a phase 4, multicenter, prospective, open-label trial that evaluated the impact of concomitant use of PFHO during contact lens wear.
Real-world PFHO data show OSDI scores falling within 2 weeks, while a 12-month trial finds stable corneal endothelial cell density with cyclosporine 0.1%.
Christopher W. Lievens, OD, MS, PhD, FAAO, FNAP, FBCLA, discusses his poster presentation titled "Latanoprostene bunod 0.024% Initiation in Medicare Fee-for-Service Patients with Open Angle Glaucoma and Ocular Hypertension."
Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
Raman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: Understanding the gene therapy landscape for retinitis pigmentosa
2
Epioxa epi-on cross-linking holds keratoconus gains at 3 years
3
AAOpt 2026: Evaluating the comfort and usability of Acuvue Vita contact lenses
4
Independent OD practices net 31% of revenue, IDOC benchmarks show
5